Bridgefront Capital, LLC Teva Pharmaceutical Industries LTD Transaction History
Bridgefront Capital, LLC
- $129 Million
- Q1 2024
A detailed history of Bridgefront Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bridgefront Capital, LLC holds 15,292 shares of TEVA stock, worth $253,082. This represents 0.17% of its overall portfolio holdings.
Number of Shares
15,292
Previous 15,683
2.49%
Holding current value
$253,082
Previous $163,000
31.9%
% of portfolio
0.17%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding TEVA
# of Institutions
540Shares Held
548MCall Options Held
19.8MPut Options Held
14M-
Black Rock Inc. New York, NY43.7MShares$723 Million0.01% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.6MShares$638 Million36.28% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L334.6MShares$572 Million7.05% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.9MShares$494 Million6.74% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L328.8MShares$477 Million4.57% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...